HCC
Conditions
Interventions
Training group:None
Sponsors
Shangluo Central Hospital
Eligibility
Sex/Gender
All
Age
25 Years to 87 Years
Inclusion criteria
Inclusion criteria: (1) All patients were diagnosed according to histopathological diagnosis or according to the Chinese HCC diagnosis and treatment guidelines and BCLC staging system; (2) Patients with complete, clear contrast-enhanced CT image data; (3) Patients with CT images obtained within 1 week prior to TACE treatment; (4) patients receiving TACE as initial therapy; (5) Patients with follow-up for more than 6 months.
Exclusion criteria
Exclusion criteria: (1) Patients with missing CT imaging data before TACE treatment; (2) Patients who have received other prior systemic or local anti-tumor therapy, such as surgical resection, radiotherapy, chemotherapy, targeted therapy, immunotherapy, or ablation; (3) patients with a follow-up of less than 6 months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| TACE response (TR);no-TACE response (nTR); | — |
Countries
China
Contacts
Public ContactBo Li
Shangluo Central Hospital
Outcome results
None listed